- Home
- FINW vs PSNL Comparison
FINW vs PSNL Comparison
Compare FINW & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FINW
- PSNL
- Stock Information
- Founded
- FINW 1999
- PSNL 2011
- Country
- FINW United States
- PSNL United States
- Employees
- FINW N/A
- PSNL N/A
- Industry
- FINW Commercial Banks
- PSNL Medical Specialities
- Sector
- FINW Finance
- PSNL Health Care
- Exchange
- FINW Nasdaq
- PSNL Nasdaq
- Market Cap
- FINW 235.6M
- PSNL 245.1M
- IPO Year
- FINW 2021
- PSNL 2019
- Fundamental
- Price
- FINW $18.08
- PSNL $3.47
- Analyst Decision
- FINW Buy
- PSNL Strong Buy
- Analyst Count
- FINW 3
- PSNL 4
- Target Price
- FINW $18.67
- PSNL $6.81
- AVG Volume (30 Days)
- FINW 22.7K
- PSNL 620.1K
- Earning Date
- FINW 01-27-2025
- PSNL 11-06-2024
- Dividend Yield
- FINW N/A
- PSNL N/A
- EPS Growth
- FINW N/A
- PSNL N/A
- EPS
- FINW 1.06
- PSNL N/A
- Revenue
- FINW $69,509,000.00
- PSNL $87,489,000.00
- Revenue This Year
- FINW N/A
- PSNL $15.76
- Revenue Next Year
- FINW $11.00
- PSNL $4.02
- P/E Ratio
- FINW $17.59
- PSNL N/A
- Revenue Growth
- FINW 4.87
- PSNL 24.05
- 52 Week Low
- FINW $8.72
- PSNL $1.12
- 52 Week High
- FINW $20.50
- PSNL $7.20
- Technical
- Relative Strength Index (RSI)
- FINW 61.78
- PSNL 46.18
- Support Level
- FINW $17.31
- PSNL $3.36
- Resistance Level
- FINW $20.50
- PSNL $4.14
- Average True Range (ATR)
- FINW 0.79
- PSNL 0.27
- MACD
- FINW 0.04
- PSNL 0.04
- Stochastic Oscillator
- FINW 55.81
- PSNL 54.22
About FINW FinWise Bancorp
FinWise Bancorp is an independent bank that provides a full range of banking services to individual and corporate customers. The bank's primary source of revenue is from loans including Small Business Administration, commercial, commercial real estate, residential real estate, and consumer. The Bank also has established Strategic Programs with various third-party loan origination platforms that use technology to streamline the origination of unsecured consumer and secured or unsecured business loans to borrowers within certain approved credit profiles.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.